(Q43130009)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

K Jordan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

H H Wolf

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

W Voigt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

T Kegel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

L P Mueller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

T Behlendorf

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C Sippel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

H J Schmoll

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

15 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1704-1709

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2010.50

19 January 2020

exact match

0 references

cites work

High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Targeted therapy of cancer: new prospects for antibodies and immunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: implications for tumor growth, metastasis, and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Neurological complications of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Evaluating risk factors for the development of ifosfamide encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Reversible posterior leukoencephalopathy syndrome and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Neurological adverse effects caused by cytotoxic and targeted therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Soft tissue sarcoma trials: one size no longer fits all.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

Testicular non-seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

7 January 2021

Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

7 January 2021

Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

7 January 2021

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

7 January 2021

Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

7 January 2021

Randomized, phase II study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.50

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228848%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

19 January 2020

1017429514

0 references

1 reference